Stock Talk Cannabis Report image of cannabis plants and VW van
(Source: File)

Glow Lifetech Corp. provided a commercial update highlighting continued progress in scaling its operations and expanding its innovative product portfolio. Glow has commissioned a new automated bottling line to support its growth trajectory and secured a new Ontario product listing for MOD CBG:THC Drops 300, introducing the emerging minor cannabinoid CBG.

(Source: Glow Lifetech Corp.)

Click here for the full story.

Weekly Update – Top Cannabis News Stories

1 | Cannabix Technologies commences first production of BreathLogix alcohol screening devices

2 | High Tide closes on $30 million convertible debt from Cronos Group

3 | Belgravia Hartford announces $5 million convertible secured debenture with Round13 DAF & closes $4 million private placement

Top Cannabis Stocks July 11 to July 17, 2025

1. T.TLRY | 7,634 views | Tilray Brands Inc.
2. T.CURA | 6,198 views | Curaleaf Holdings Inc.
3. T.LABS | 3,443 views | Medipharm Labs Corp.
4. T.WEED | 2,554 views | Canopy Growth Corp.
5. T.ACB | 705 views | Aurora Cannabis Inc.
6. C.TGIF | 549 views | 1933 Industries Inc.


The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.

Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional.

More From The Market Online

@ the Bell: TSX lifted by strong earnings from Big Six banks

The TSX Index added more than 1 per cent on Thursday driven by strong earnings from Canada’s Big Six banks.

Market Open: Salesforce Gains, EQB Buys PC Financial, Copper Slips | Dec 04, 2025

TSX rises 0.36% as Salesforce jumps 2% and EQB acquires PC Financial. Dow dips, gold edges higher, copper and Bitcoin fall.

Buzz on the Bullboards: Cannabis stock split, major financing, and battery breakthrough

Inflation concerns, lofty valuations, and growing uncertainty around returns from have prompted investors to reassess their AI exposure.